欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (3): 256-260.

• 研究原著 • 上一篇    下一篇

LC-MS 法测定Beagle 犬血浆中人参皂苷20( R) -Rh2 及其药代动力学研究

顾轶, 王广基, 孙建国, 谢海棠, 贾元威, 许美娟, 吕华, 黄晨蓉, 王玮   

  1. 中国药科大学药物代谢动力学重点实验室,南京 210009,江苏
  • 收稿日期:2005-11-25 修回日期:2006-01-07 出版日期:2006-03-26 发布日期:2020-12-04
  • 通讯作者: 王广基,男,博士,教授,博士生导师,研究方向:药代动力学。Tel:025-83271544 E-mail:guangjiwang@yahoo.com.cn
  • 作者简介:顾轶,男,博士研究生,研究方向:药代动力学。Tel:025-8539108913512543781 E-mail:gooey@vip.sina.com

Pharmacokinetic study of ginsenoside 20(R)-Rh2 in Beagle dogs by LCESI-MS

GU Yi, WANG Guang-ji, SUN Jian-guo, XIE Hai-tang, JIA Yuan-wei, XU Mei-juan, LV Hua, HUANG Cheng-rong, WANG Wei   

  1. Key Laborary of Drug Metabolism and Pharmacokinetics,China Pharmaceutical University,Nanjing 210009,Jiangsu,China
  • Received:2005-11-25 Revised:2006-01-07 Online:2006-03-26 Published:2020-12-04

摘要: 目的 建立测定人参皂苷20(R)-Rh2血浆药物浓度的液相色谱-电喷雾离子化-质谱联用的分析方法(LC-ESI-MS),探讨其在Beagle犬体内的药代动力学研究中的应用。方法 Beagle犬6只,随机分为2组,采用单剂量双周期自身交叉设计,分别给犬单剂量静注(0.1mg·kg-1)或灌胃(1mg·kg-1)20(R)-Rh2,用LC-MS法测定给药后的血浆中药物浓度,计算其药代动力学参数,以及在Beagle犬体内的绝对生物利用度。结果 20(R)-Rh2在0.5~200ng·ml-1浓度范围内线性关系良好(r2=0.9998),样品在血浆中的提取回收率大于70%,批内和批间的RSD均小于15%,静注后主要药代动力学参数T1/2,CL,AUC0-∞分别为8.0±2.8h、0.1±0.03L·kg-1·h、857.0±209.6ng·h·ml-1;口服后主要药代动力学参数Tmax,Cmax,T1/2,AUC0-∞分别为2.6±1.3h、371.0±199.6ng·ml-1、5.8±2.6h、1215.7±598.6ng·h·ml-1。绝对生物利用度为(16.1±11.3)%。结论 该法专属性强,灵敏度高,可用于20(R)-Rh2的体内定量分析。人参皂苷20(R)-Rh2在Beagle犬体内的绝对生物利用度较低。

关键词: 人参皂苷20(R)-Rh2, 液相色谱-电喷雾离子化-质谱联用法, 药代动力学, 绝对生物利用度

Abstract: AIM: To establish an LC-ESI-MS method for determination of ginsenoside 20(R)-Rh2 and investigate its application to pharmacokinetic and absolute bioavailability study in Beagle dogs.METHODS: According to a randomized two-period crossover design,beagle dogs were given 1 and 0.1mg·kg-1 20(R)-Rh2 via po and ivrespectively.Drug plasma concentration was determined by LC-ESI-MS.Pharmacokinetic parameters were evaluated and absolute bioavailability was also calculated.RESULTS: The method was linear over the range of 0.5-200ng·ml-1 (R2=0.9998);The recovery of 20(R)-Rh2 in dog plasma was more than 70%;Intra- and interbatch precision,expressed as the relative standard (RSD) was less than 15%;After iv administration of 20 (R)-Rh2,the main pharmacokinetic parameters T1/2,CL,AUC0-∞ were 8.0±2.8h,0.1±0.03L·kg-1·h-1,857.0±209.6ng·h·ml-1 respectively;after po administration,the major pharmacokinetic parameters Tmax,Cmax,T1/2,AUC0-∞ were 2.6±1.3 h,371.0±199.6ng·ml-1,5.8±2.6 h,1215.7±598.6ng·h·ml-1 respectively.The absolute bioavailability was 16.1%±11.3% after the correction of dosage.CONCLUSION: The method described in this report was sensitive and specific,and suitable for pharmacokinetic studies of 20(R)-Rh2 in dog.The absolute bioavailability of 20(R)-Rh2 in dog was relative low.

Key words: ginsenoside 20 ( R) -Rh2, LC-ESI-MS, pharmacokinetics, absolute bioavailability

中图分类号: